Tekla Capital Management’s Charles River Laboratories CRL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q2
$23.4M Sell
111,183
-6,900
-6% -$1.45M 0.91% 33
2023
Q1
$23.8M Buy
118,083
+45,408
+62% +$9.16M 0.91% 31
2022
Q4
$15.8M Hold
72,675
0.6% 41
2022
Q3
$14.3M Buy
72,675
+24,781
+52% +$4.88M 0.59% 42
2022
Q2
$10.2M Sell
47,894
-14,096
-23% -$3.02M 0.4% 59
2022
Q1
$17.6M Hold
61,990
0.62% 44
2021
Q4
$23.4M Sell
61,990
-16,494
-21% -$6.21M 0.75% 36
2021
Q3
$32.4M Buy
78,484
+23,810
+44% +$9.83M 1.04% 30
2021
Q2
$20.2M Buy
54,674
+11,600
+27% +$4.29M 0.66% 41
2021
Q1
$12.5M Buy
43,074
+14,920
+53% +$4.32M 0.43% 61
2020
Q4
$7.04M Sell
28,154
-2,600
-8% -$650K 0.25% 102
2020
Q3
$6.96M Buy
30,754
+12,287
+67% +$2.78M 0.26% 87
2020
Q2
$3.22M Hold
18,467
0.12% 134
2020
Q1
$2.33M Sell
18,467
-2,500
-12% -$316K 0.11% 127
2019
Q4
$3.2M Sell
20,967
-4,100
-16% -$626K 0.12% 135
2019
Q3
$3.32M Buy
25,067
+10,900
+77% +$1.44M 0.14% 109
2019
Q2
$2.01M Buy
14,167
+3,527
+33% +$500K 0.08% 133
2019
Q1
$1.55M Sell
10,640
-12,030
-53% -$1.75M 0.06% 140
2018
Q4
$2.57M Hold
22,670
0.11% 116
2018
Q3
$3.05M Hold
22,670
0.11% 122
2018
Q2
$2.55M Hold
22,670
0.1% 127
2018
Q1
$2.42M Sell
22,670
-63,134
-74% -$6.74M 0.09% 127
2017
Q4
$9.39M Sell
85,804
-41,296
-32% -$4.52M 0.36% 56
2017
Q3
$13.7M Hold
127,100
0.49% 40
2017
Q2
$12.9M Hold
127,100
0.48% 49
2017
Q1
$11.4M Sell
127,100
-500
-0.4% -$45K 0.44% 50
2016
Q4
$9.72M Buy
127,600
+12,600
+11% +$960K 0.41% 58
2016
Q3
$9.58M Buy
+115,000
New +$9.58M 0.37% 63